This research compound was first documented by Hoffman-La Roche in 2009. It’s considered one of quite a few benzodiazepines inside the imidazobenzodiazepine subgroup thought to offer nootropic Rewards. It’s unclear why this drug wasn’t investigated further more, but you'll find reviews this compound has long been detected on designer and https://karli554dvm5.answerblogs.com/profile